Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Consumer Chief Sees Chronic Conditions In OTC Future

This article was originally published in The Tan Sheet

Executive Summary

Future OTC switches of drugs for chronic conditions like high cholesterol could "fundamentally help" alter the health care environment and lower costs, says Pfizer Consumer Healthcare President Paul Sturman.
Advertisement

Related Content

J&J’s Problems, Pfizer’s Options And Switch Outlook Top “The Tan Sheet” Topics In 2011
J&J’s Problems, Pfizer’s Options And Switch Outlook Top “The Tan Sheet” Topics In 2011
Lipitor OTC Switch Would Force Pfizer To Clear Big Research Hurdles
Lipitor OTC Switch Would Force Pfizer To Clear Big Research Hurdles
Lipitor OTC Switch Would Force Pfizer To Clear Big Research Hurdles
Pfizer Will Unload Nutrition Division, Keep Consumer Product Unit
Pfizer Will Unload Nutrition Division, Keep Consumer Product Unit
Pfizer CEO Read Expects Gradual Plans For Change In Second Half 2011
Pfizer CEO Read Expects Gradual Plans For Change In Second Half 2011
CDER Director Sees Behind-The-Counter Switches As Best Bet

Topics

Advertisement
UsernamePublicRestriction

Register

PS105089

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel